NORAD and head and neck squamous cell carcinoma: Thus, NORAD knockdown in HNSCC-derived tumor stem cells attenuates migration and invasion, lowers the expression levels of EMT-related markers, like MMP2, MMP9, N-cadherin, and vimentin, and upregulates E-cadherin expression [96].